We are on a mission to impact patients’ lives.
We have potentially groundbreaking clinical-stage therapies in development that, if approved, offer an innovative approach to essential areas of dermatology.
Learn who we are and what we do
More information about the therapeutic areas we are addressing
Learn about the potentially groundbreaking treatments we are developing for the marketplace
Information for investors
We are proud to announce the FDA approval of our first treatment
WINLEVI® (clascoterone) cream 1%
Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange
Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange
Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange
Breezula is under investigation in the United States for the treatment of androgenetic alopecia, and the safety and efficacy have not been established by the United States Food and Drug Administration (FDA). The proposed brand name for clascoterone solution 7.5% is not FDA-approved.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc placerat consequat massa. Integer et imperdiet dolor. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nullam in sapien in eros imperdiet iaculis vel quis leo. Nullam risus tortor, ornare ut risus non, bibendum pretium nulla. Sed eu sollicitudin orci. Nam pretium lectus non purus cursus scelerisque. Nunc felis arcu, lacinia dignissim condimentum sed, ultrices a turpis. In nibh urna, auctor vel ornare id, ornare sed orci. Donec ultrices elit quis ipsum sagittis tristique. Etiam finibus tortor id felis varius, eu accumsan nisl rutrum. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer sed nisl mollis, lacinia lectus nec, porta lectus. In placerat orci diam, ornare sodales enim ornare sed. Pellentesque aliquet, leo quis pulvinar porta, sapien ex cursus leo, ut porta eros justo vitae elit. Morbi consequat ac augue et rhoncus. Phasellus aliquet arcu nisi, sed lacinia mi tristique ac. Quisque ultrices, arcu vitae pulvinar pellentesque, mi orci ultrices felis, a pulvinar diam nulla id mauris. Duis a ante sem. Sed ac ex non tortor ornare viverra nec in magna. Lorem ipsum dolor sit amet, consectetur adipiscing elit. In dictum tellus eget sagittis interdum. In ante sem, pellentesque a ultrices non, ultrices id odio. Curabitur at lacinia elit, ut placerat lectus. Morbi sollicitudin sapien vitae rhoncus dapibus.
